EUVIMEDSkopri EUVIMED
Crossref

Structural heterogeneity of apolipoprotein B‐100

Altaira D Dearborn, Alan T Remaley, Joseph Marcotrigiano iD

The FEBS Journal · 2026

DOI: 10.1111/febs.70451 ↗

At a glance

Journal article in The FEBS Journal, 2026. Written by Altaira D Dearborn and 2 co-authors. Institution: Structural Virology Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health,…. Major MEDLINE topics: Apolipoprotein B-100, Lipoproteins, LDL, Receptors, LDL. 22 references. Funded by: NHLBI NIH HHS, National Institute of Allergy and Infectious Diseases, Leducq Foundation for Cardiovascular Research.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Cardiovascular disease is a major cause of human morbidity and mortality. Drug strategies for the prevention of the disease are largely centered on the interaction of low‐density lipoprotein receptor (LDLR) with the apolipoprotein B‐100 (apoB‐100) protein on low‐density lipoprotein (LDL). Recently, the structure of apoB‐100 on LDL was determined in the absence and presence of LDLR, using cryo‐electron microscopy. A remarkable structural feature of apoB‐100 is the lack of any significant tertiary structure within the C‐terminal two‐thirds of the protein (>3000 residues). Instead, apoB‐100 forms amphipathic helices and β‐sheets on the phospholipid surface of LDL, which envelops its neutral lipid core. The apoB‐100 ligand binding domain for LDLR includes multiple points on a circumferential β‐belt and on the N terminus. In the course of this study, we also observed several instances of structural heterogeneity in apoB‐100. The various conformations may allow apoB‐100 to accommodate different size lipoprotein particles and to permit recognition by other apolipoproteins or receptors.

Subjects

MeSH terms (MEDLINE)

Apolipoprotein B-100Lipoproteins, LDLReceptors, LDLAnimalsHumansCryoelectron MicroscopyModels, MolecularProtein BindingProtein Conformation

Author keywords

LDLLDL receptorapolipoprotein B‐100cardiovascular diseasecholesterol

Substances

Apolipoprotein B-100Lipoproteins, LDLReceptors, LDL

Authors and institutions

  • Structural Virology Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Lipoprotein Metabolism Laboratory, Translational Vascular Medicine Branch, National, Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.

ORCID profiles: Joseph Marcotrigiano

Funding

  • NHLBI NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • Leducq Foundation for Cardiovascular Research
  • Division of Intramural Research
  • National Heart, Lung, and Blood Institute

Cite

APA

Dearborn, A. D., Remaley, A. T., & Marcotrigiano, J. (2026). Structural heterogeneity of apolipoprotein B‐100. The FEBS Journal. https://doi.org/10.1111/febs.70451

Vancouver

Dearborn AD, Remaley AT, Marcotrigiano J. Structural heterogeneity of apolipoprotein B‐100. The FEBS Journal. 2026. doi:10.1111/febs.70451

BibTeX
@article{Dearborn2026,
  author = {Dearborn, Altaira D and Remaley, Alan T and Marcotrigiano, Joseph},
  title = {Structural heterogeneity of apolipoprotein B‐100},
  journal = {The FEBS Journal},
  year = {2026},
  doi = {10.1111/febs.70451}
}
Start for free →